You are here:
Home / Archives for Avigen
In the United States, up to 50 million people live with chronic pain, with the majority of these patients not satisfied with their current pain treatments. Pain is defined clinically as an unpleasant emotional experience resulting from real or potential tissue damage and is generally divided into two categories based on cause:
Nociceptive pain, which is [...]
Filed under Articles · Tagged with ACAD, ACADIA Pharmaceuticals, ADL5859, ADLR, Adolor Corporation, AEG33773, Aegera Therapeutics, AGN, AGN 0001, AGN XX/YY, Allergan, alpha tocopheryl phosphate, AV411, AVGN, Avigen, axomadol, BIIB, Biogen Idec, Endo Pharmaceuticals, ENDP, ExonHit Therapeutics, gabapentin enacarbil, GlaxoSmithKline, Grunenthal, GSK, ICA-105665, Icagen, ICGN, ion channel, NAV1.7, Neublastin, Neuropathic Pain, Newron Pharmaceutics, Nitec Pharma AG, nociceptive, NsGene A/S, PFE, Pfizer, Phosphagenics Limited, TruNoc, Xenoport, XNPT, XP13512
Parkinson’s disease [PD] is one of the most common of the neurogenerative diseases affecting 1 in 100 people over the age of 60. Approximately 1.5 million Americans currently suffer from the disease and it is estimated that 60,000 Americans are newly diagnosed each year. PD is both a chronic and progressive disease.
While the precise cause [...]
Filed under Articles · Tagged with AAV, Addex Pharmaceuticals, adeno-associated virus, Amgen, AMGN, Amicus Therapeutics, Amsterdam Molecular Therapeutics, AVGN, Avigen, BDNF, CERE-120, Ceregene, CNS Protein Therapeutics, deep brain stimulation, DEPO, Depomed, dopamine, dopaminergic neurons, FOLD, GDNF, gene therapy, GENZ, Genzyme Corporation, glutamic acid decarboxylase, Impax Pharmaceuticals, Inc., IPX066, IPXL, L-dopa, LentiVector, levodopa, MANF, MDT, Medtronic, mesencephalic astrocyte-derived neurotrophic factor, Neurogen Corporation, Neurologix, neurotrophic factors, neurturin, NLX-P101, NRGN, NRGX, Oxford BioMedica, Parkinson's disease, PRAN, Prana Biotechnology, ProSavin, SynchoMed, Synergen, Unified Parkinson’s Disease Rating Scale